Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis

Digestive Diseases and Sciences

Volumn 55, Issue 2, 2010, Pages 276-284

  Karantonis, Haralabos C ^a,b   Gribilas, Georgios ^a   Stamoulis, Ioannis ^a,b   Giaginis, Constantinos ^a,b   Spiliopoulou, Chara ^a   Kouraklis, Gregorios ^b   Demopoulos, Constantinos ^b   Theocharis, Stamatios E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cirrhosis; Fibrosis; Liver; PAF; PAF AH; Thioacetamide

Indexed keywords

THIOACETAMIDE; THROMBOCYTE ACTIVATING FACTOR; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; LIPID BLOOD LEVEL; LIVER; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE COURSE; DRUG EFFECT; EXPERIMENTAL LIVER CIRRHOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITALIZATION; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MALONDIALDEHYDE; PLATELET ACTIVATING FACTOR; RATS; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; THIOACETAMIDE;

EID: 76849087846     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0745-0     Document Type: Article

References (57)

1. R Bataller DA Brenner 2005 Liver fibrosis J Clin Invest 115 209 218 1:CAS:528:DC%2BD2MXhtFyjs70%3D 15690074
2. SL Friedman 2003 Liver fibrosis-from bench to bedside J Hepatol 38 S38 S53 10.1016/S0168-8278(02)00429-4 12591185 (Pubitemid 39658635)
3. M Pinzani K Rombouts 2004 Liver fibrosis: from the bench to clinical targets Dig Liver Dis 36 231 242 10.1016/j.dld.2004.01.003 1:STN:280: DC%2BD2c3hslWgtQ%3D%3D 15115333 (Pubitemid 41115470)
4. A Canbay S Friedman GJ Gores 2004 Apoptosis: the nexus of liver injury and fibrosis Hepatology 39 273 278 10.1002/hep.20051 14767974 (Pubitemid 38222163)
5. G Ramadori B Saile 2004 Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question Gastroenterology 127 997 1000 10.1053/j.gastro.2004.07.041 1:CAS:528:DC%2BD2cXovVSrsb0%3D 15362057 (Pubitemid 39208434)
6. M Sato S Suzuki H Senoo 2003 Hepatic stellate cells: unique characteristics in cell biology and phenotype Cell Struct Funct 28 105 112 10.1247/csf.28.105 1:CAS:528:DC%2BD3sXlslOgs7s%3D 12808230
7. G Poli 2000 Pathogenesis of liver fibrosis: role of oxidative stress Mol Aspects Med 21 49 98 10.1016/S0098-2997(00)00004-2 1:CAS:528: DC%2BD3cXmt1Sgu74%3D 10978499 (Pubitemid 30642764)
8. H Tsukamoto M Matsuoka SW French 1990 Experimental models of hepatic fibrosis: a review Semin Liver Dis 10 56 65 10.1055/s-2008-1040457 1:STN:280:DyaK3c3ks1ajsg%3D%3D 2110685
9. GM Ledda-Columbano P Coni M Curto, et al. 1991 Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide Am J Pathol 139 1099 1109 1:CAS:528:DyaK38XltlSqtw%3D%3D 1683163
10. AL Hunter MA Holscher RA Neal 1977 Thioacetamide-induced hepatic necrosis. I. Involvement of the mixed-function oxidase enzyme system J Pharmacol Exp Ther 200 439 448 1:CAS:528:DyaE2sXks1emtLs%3D 839448
11. MI Torres MI Fernandez A Gil A Rios 1998 Dietary nucleotides have cytoprotective properties in rat liver damaged by thioacetamide Life Sci 62 13 22 10.1016/S0024-3205(97)01033-3 1:CAS:528:DyaK2sXnvFWmtrY%3D 9444963
12. M Constantinou SE Theocharis E Mikros 2007 Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats Toxicol Appl Pharmacol 218 11 19 10.1016/j.taap.2006.10.007 1:CAS:528:DC%2BD2sXitl2isg%3D%3D 17113614 (Pubitemid 46026839)
13. E Chieli G Malvaldi 1984 Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide Toxicology 31 41 52 10.1016/0300-483X(84)90154-9 1:CAS:528:DyaL2cXkvVGisbk%3D 6729835 (Pubitemid 14120881)
14. TY Low CK Leow M Salto-Tellez MC Chung 2004 A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers Proteomics 4 3960 3974 10.1002/pmic.200400852 1:CAS:528:DC%2BD2cXhtFarsb%2FN 15526343 (Pubitemid 39657471)
15. J Chilakapati K Shankar MC Korrapati RA Hill HM Mehendale 2005 Saturation toxicokinetics of thioacetamide: role in initiation of liver injury Drug Metab Dispos 33 1877 1885 1:CAS:528:DC%2BD2MXht1ygu7bK 16183780
16. JW Lee KD Shin M Lee, et al. 2003 Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression Toxicol Lett 136 163 172 10.1016/S0378-4274(02)00333-8 1:CAS:528:DC%2BD38XpslSitbY%3D 12505269 (Pubitemid 36005464)
17. G Ekstrom M Ingelman-Sundberg 1989 Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1) Biochem Pharmacol 38 1313 1319 10.1016/0006- 2952(89)90338-9 1:STN:280:DyaL1M3gs1yiug%3D%3D 2495801 (Pubitemid 19101961)
18. N Sanz C Díez-Fernandez D Andres M Cascales 2002 Hepatotoxicity and aging: endogenous antioxidant systems in hepatocytes from 2-, 6-, 12-, 18- and 30-month-old rats following a necrogenic dose of thioacetamide Biochim Biophys Acta 1587 12 20 1:CAS:528:DC%2BD38XjsFygsLo%3D 12009419
19. EC So KL Wong TC Huang SC Tasi CF Liu 2002 Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity J Biomed Sci 9 410 414 10.1007/BF02256534 1:CAS:528:DC%2BD38XmvFajsLg%3D 12218355
20. C Díez-Fernandez L Bosca L Fernandez-Simon A Alvarez M Cascales 1993 Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide Hepatology 18 912 918 10.1002/hep.1840180424 8406367
21. SK Ramaiah U Apte HM Mehendale 2001 Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats Drug Metab Dispos 29 1088 1095 1:CAS:528:DC%2BD3MXlsVChtLo%3D 11454726
22. T Wang K Shankar MJ Ronis HM Mehendale 2000 Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1 J Pharmacol Exp Ther 294 473 479 1:CAS:528:DC%2BD3cXltlKgs7g%3D 10900221
23. CA Demopoulos RN Pinckard DJ Hanahan 1979 Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators) J Biol Chem 254 9355 9358 1:CAS:528:DyaE1MXlsFGru7k%3D 489536
24. SM Prescott GA Zimmerman DM Stafforini TM McIntyre 2000 Platelet-activating factor and related lipid mediators Annu Rev Biochem 69 419 445 10.1146/annurev.biochem.69.1.419 1:CAS:528:DC%2BD3cXnt1ajtbs%3D 10966465 (Pubitemid 30792216)
25. TA Imaizumi DM Stafforini Y Yamada TM McIntyre SM Prescott GA Zimmerman 1995 Platelet-activating factor: a mediator for clinicians J Intern Med 238 5 20 10.1111/j.1365-2796.1995.tb00894.x 1:CAS:528:DyaK2MXnsVemu70%3D 7608647
26. PV Peplow 1999 Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers Prostaglandins Leukot Essent Fatty Acids 61 65 82 10.1054/plef.1999.0038 1:CAS:528:DyaK1MXmt1Gmtro%3D 10509861 (Pubitemid 29454327)
27. W Chao MS Olson 1993 Platelet-activating factor: receptors and signal transduction Biochem J 292 617 629 1:CAS:528:DyaK3sXksVGru74%3D 8391253
28. LW Tjoelker DM Stafforini 2000 Platelet-activating factor acetylhydrolases in health and disease Biochim Biophys Acta 1488 102 123 1:CAS:528:DC%2BD3cXotlGitr0%3D 11080681
29. K Karasawa A Harada N Satoh K Inoue M Setaka 2003 Plasma platelet-activating factor-acetylhydrolase (PAF-AH) Prog Lipid Res 42 93 114 10.1016/S0163-7827(02)00049-8 1:CAS:528:DC%2BD3sXltVKntg%3D%3D 12547653 (Pubitemid 36120431)
30. TM McIntyre GA Zimmerman SM Prescott 1999 Biologically active oxidized phospholipids J Biol Chem 274 25189 25192 10.1074/jbc.274.36.25189 1:CAS:528:DyaK1MXmtVWit74%3D 10464236 (Pubitemid 29418529)
31. GK Marathe SM Prescott GA Zimmerman TM McIntyre 2001 Oxidized LDL contains inflammatory PAF-like phospholipids Trends Cardiovasc Med 11 139 142 10.1016/S1050-1738(01)00100-1 1:CAS:528:DC%2BD3MXntFGgsbw%3D 11686003 (Pubitemid 33070337)
32. NP Karidis G Kouraklis SE Theocharis 2006 Platelet-activating factor in liver injury: a relational scope World J Gastroenterol 12 3695 3706 16773686
33. C Caramelo S Fernandez-Gallardo JC Santos, et al. 1987 Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver Eur J Clin Invest 17 7 11 10.1111/j.1365-2362.1987.tb01218.x 1:STN:280:DyaL2s7ptVKmtg%3D%3D 3106053
34. P Moreno MA Gijon R Fradera, et al. 1993 Changes in peripheral blood levels of platelet-activating factor after orthotopic liver transplantation Transplant Proc 25 2642 2653 1:STN:280:DyaK3szmt1aqtA%3D%3D 8395105
35. J Sugatani M Miwa Y Komiyama T Murakami 1993 Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation J Immunol Methods 166 251 261 10.1016/0022-1759(93)90366-F 1:CAS:528:DyaK2cXhsFOqurk%3D 8288878
36. G Laffi V Carloni E Baldi, et al. 1993 Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis Gastroenterology 105 170 177 1:STN:280:DyaK3s3pt1yjuw%3D%3D 8390378
37. T Kamisako K Takeuchi T Ito S Tamaki T Kosaka Y Adachi 2003 Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with hyperbilirubinemic hepatobiliary disease Hepatol Res 26 23 27 10.1016/S1386-6346(03)00006-8 1:CAS:528:DC%2BD3sXkt1Kgsb0%3D 12787800 (Pubitemid 36939927)
38. CJ Meade S Metcalfe R Svvennsen, et al. 1991 Serum PAF acetylhydrolase and chronic cholestasis Lancet 338 1016 1017 10.1016/0140-6736(91)91876-V 1:STN:280:DyaK38%2Fhs12htg%3D%3D 1681319
39. LM Villamediana E Sanz S Fernandez-Gallardo, et al. 1986 Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver Life Sci 39 201 205 10.1016/0024-3205(86) 90531-X 1:CAS:528:DyaL28XkslKqsbk%3D 3755490 (Pubitemid 16061876)
40. Y Yang EM Nemoto SA Harvey VM Subbotin CR Gandhi 2004 Increased hepatic platelet-activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis Gut 53 877 883 10.1136/gut.2003.024893 1:CAS:528:DC%2BD2cXlt1eltrY%3D 15138217 (Pubitemid 38662140)
41. 4-induced cirrhotic rat liver J Hepatol 39 200 207 10.1016/S0168-8278(03)00229-0 1:CAS:528:DC%2BD3sXlsVWlurY%3D 12873816 (Pubitemid 36920555)
42. Gribilas G, Zarros A, Zira A, et al. Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat. Dig Dis Sci. 2009 (in press).
43. A Muller F Machnik T Zimmermann H Schubert 1988 Thioacetamide-induced cirrhosis-like liver lesions in rats-usefulness and reliability of this animal model Exp Pathol 34 229 236 1:STN:280:DyaL1M7ntFWgug%3D%3D 2853079
44. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 10.1016/0003-2697(79) 90738-3 1:CAS:528:DyaE1MXksFaisbk%3D 36810 (Pubitemid 9194347)
45. O Lowry N Rosebrough A Farr R Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
46. CA Demopoulos NK Andrikopoulos S Antonopoulou 1994 A simple and precise method for the routine determination of platelet-activating factor in blood and urine Lipids 29 305 309 10.1007/BF02536336 1:CAS:528:DyaK2cXis1GhtLg%3D 8177023
47. EG Bligh WJ Dyer 1959 A rapid method of total lipid extraction and purification Can J Biochem Physiol 37 911 917 1:CAS:528:DyaG1MXhtVSgt70%3D 13671378
48. HC Karantonis S Antonopoulou DN Perrea, et al. 2006 In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits Nutr Metab Cardiovasc Dis 16 174 185 10.1016/j.numecd. 2005.07.003 1:CAS:528:DC%2BD1cXhvVertL0%3D 16580585
49. J Carvalho-Tavares A Fox-Robichaud P Kubes 1999 Assessment of the mechanism of juxtacrine activation and adhesion of leukocytes in liver microcirculation Am J Physiol 276 G828 G834 1:CAS:528:DyaK1MXislCmurY%3D 10198324
50. N Sanz C Díez-Fernandez L Fernandez-Simon A Alvarez M Cascales 1995 Relationship between antioxidant systems, intracellular thiols and DNA ploidy in liver of rats during experimental cirrhogenesis Carcinogenesis 16 1585 1593 10.1093/carcin/16.7.1585 1:CAS:528:DyaK2MXntVOhtb4%3D 7614693
51. H Abul TC Mathew HM Dashti A Al-Bader 2002 Level of superoxide dismutase, glutathione peroxidase and uric acid in thioacetamide-induced cirrhotic rats Anat Histol Embryol 31 66 71 10.1046/j.1439-0264.2002.00359.x 1:STN:280:DC%2BD38zhtlCjtw%3D%3D 12047241
52. TA Liapikos S Antonopoulou SP Karabina DC Tsoukatos CA Demopoulos AD Tselepis 1994 Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated Biochim Biophys Acta 1212 353 360 1:CAS:528:DyaK2cXltVGjurc%3D 8199206
53. M Pinzani F Marra 2001 Cytokine receptors and signaling in hepatic stellate cells Semin Liver Dis 21 397 416 10.1055/s-2001-17554 1:CAS:528:DC%2BD3MXnvVant7g%3D 11586468 (Pubitemid 32923768)
54. K Hattori M Hattori H Adachi M Tsujimoto H Arai K Inoue 1995 Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol J Biol Chem 270 22308 22313 10.1074/jbc.270.38.22308 1:CAS:528:DyaK2MXot1Ghsbs%3D 7673213
55. AP Bautista JJ Spitzer 1992 Platelet-activating factor stimulates and primes the liver, Kupffer cells and neutrophils to release superoxide anion Free Radic Res Commun 17 195 209 10.3109/10715769209068166 1:CAS:528: DyaK3sXlvVSltg%3D%3D 1334036
56. CR Gardner JD Laskin DL Laskin 1993 Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells J Leukoc Biol 53 190 196 1:CAS:528:DyaK3sXktVGmsLY%3D 8383168
57. CR Gardner JD Laskin DL Laskin 1995 Distinct biochemical responses of hepatic macrophages and endothelial cells to platelet-activating factor during endotoxemia J Leukoc Biol 57 269 274 1:CAS:528:DyaK2MXjsFOht7s%3D 7852841